<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhao D</submitter><funding>Postdoctoral Science Foundation of China</funding><funding>National Natural Science Foundation of China</funding><pagination>e3003047</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11960969</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(4)</volume><pubmed_abstract>Memprin/A5/mu (MAM) domain containing glycosylphosphatidylinositol anchor 2 (MDGA2) is an excitatory synaptic suppressor and its mutations have been associated with autism spectrum disorder (ASD). However, the detailed physiological function of MDGA2 and the mechanism underlying MDGA2 deficiency-caused ASD has yet to be elucidated. Herein, we not only confirm that Mdga2 +/- mice exhibit increased excitatory synapse transmission and ASD-like behaviors, but also identify aberrant brain-derived neurotrophic factor/tyrosine kinase B (BDNF/TrkB) signaling activation in these mice. We demonstrate that MDGA2 interacts with TrkB through its memprin/A5/mu domain, thereby competing the binding of BDNF to TrkB. Both loss of MDGA2 and the ASD-associated MDGA2 V930I mutation promote the BDNF/TrkB signa</pubmed_abstract><journal>PLoS biology</journal><pubmed_title>Mdga2 deficiency leads to an aberrant activation of BDNF/TrkB signaling that underlies autism-relevant synaptic and behavioral changes in mice.</pubmed_title><pmcid>PMC11960969</pmcid><funding_grant_id>2022M722651</funding_grant_id><funding_grant_id>U21A20361</funding_grant_id><funding_grant_id>82001442</funding_grant_id><funding_grant_id>2020M671948</funding_grant_id><funding_grant_id>82130039</funding_grant_id><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Zheng N</pubmed_authors><pubmed_authors>Huo Y</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Zhang YW</pubmed_authors><pubmed_authors>Zhu X</pubmed_authors><pubmed_authors>Zhao D</pubmed_authors><pubmed_authors>Yang D</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mdga2 deficiency leads to an aberrant activation of BDNF/TrkB signaling that underlies autism-relevant synaptic and behavioral changes in mice.</name><description>Memprin/A5/mu (MAM) domain containing glycosylphosphatidylinositol anchor 2 (MDGA2) is an excitatory synaptic suppressor and its mutations have been associated with autism spectrum disorder (ASD). However, the detailed physiological function of MDGA2 and the mechanism underlying MDGA2 deficiency-caused ASD has yet to be elucidated. Herein, we not only confirm that Mdga2 +/- mice exhibit increased excitatory synapse transmission and ASD-like behaviors, but also identify aberrant brain-derived neurotrophic factor/tyrosine kinase B (BDNF/TrkB) signaling activation in these mice. We demonstrate that MDGA2 interacts with TrkB through its memprin/A5/mu domain, thereby competing the binding of BDNF to TrkB. Both loss of MDGA2 and the ASD-associated MDGA2 V930I mutation promote the BDNF/TrkB signa</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2026-06-01T19:21:13.207Z</modification><creation>2025-06-26T03:06:08.004Z</creation></dates><accession>S-EPMC11960969</accession><cross_references><pubmed>40168357</pubmed><doi>10.1371/journal.pbio.3003047</doi></cross_references></HashMap>